Intracellular doppler imaging clinical trials in personalized cancer care

David D. Nolte, Zhe Li, Honggu Choi, Michael Childress, John Turek, Shadia Jalal

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Clinical trials of biodynamic digital holography in human esophageal cancer and canine B-cell lymphoma, performed within 24 hours of biopsy acquisition, have an accuracy of 90% identifying patients resistant to their prescribed chemotherapy. Translation of this biomedical optical technology to clinical laboratory services has the potential to transform personalized cancer care.

Original languageEnglish (US)
Title of host publicationCLEO
Subtitle of host publicationApplications and Technology, CLEO_AT 2018
PublisherOSA - The Optical Society
ISBN (Electronic)9781557528209
DOIs
StatePublished - Jan 1 2018
EventCLEO: Applications and Technology, CLEO_AT 2018 - San Jose, United States
Duration: May 13 2018May 18 2018

Publication series

NameOptics InfoBase Conference Papers
VolumePart F92-CLEO_AT 2018

Other

OtherCLEO: Applications and Technology, CLEO_AT 2018
CountryUnited States
CitySan Jose
Period5/13/185/18/18

ASJC Scopus subject areas

  • Electronic, Optical and Magnetic Materials
  • Mechanics of Materials

Fingerprint Dive into the research topics of 'Intracellular doppler imaging clinical trials in personalized cancer care'. Together they form a unique fingerprint.

  • Cite this

    Nolte, D. D., Li, Z., Choi, H., Childress, M., Turek, J., & Jalal, S. (2018). Intracellular doppler imaging clinical trials in personalized cancer care. In CLEO: Applications and Technology, CLEO_AT 2018 (Optics InfoBase Conference Papers; Vol. Part F92-CLEO_AT 2018). OSA - The Optical Society. https://doi.org/10.1364/CLEO_AT.2018.ATu4J.6